Comparar métodos

	Drug Use Disorders Identification Test (DUDIT)	Brief Addiction Monitor (BAM)	Teste de Identificação de Transtorno por Uso de Cannabis	Questionário de Gravidade da Dependência de Álcool (SADQ)
Área	Medicina das dependências	Medicina das dependências	Medicina das dependências	Medicina das dependências
Família	Process / pipeline	Process / pipeline	Process / pipeline	Process / pipeline
Ano de origem	2005	2013	2010	1979
Autor original	Berman, Bergman, Palmstierna, Schlyter	Cacciola, Alterman, Drapkin, Valadez	Adamson, Kay-Lambkin, Baker, Lewin, Thornton, Kelly, Sellman	Stockwell, Murphy, Hodgson
Tipo	Self-report	Self-report	Self-report	Self-report
Fonte seminal	Berman, A. H., Bergman, H., Palmstierna, T., & Schlyter, F. (2005). Evaluation of the Drug Use Disorder Identification Test (DUDIT) in criminal justice and detoxification settings and in a Swedish population sample. European Addiction Research, 11(1), 22–31.	Cacciola, J. S., Alterman, A. I., Drapkin, M. L., & Valadez, C. (2013). Development and initial validation of the Brief Addiction Monitor (BAM). Journal of Substance Abuse Treatment, 44(3), 256–263.	Adamson, S. J., Kay-Lambkin, F. J., Baker, A. L., Lewin, T. J., Thornton, L., Kelly, B. J., & Sellman, J. D. (2010). An improved brief screening instrument for cannabis use disorder. Drug and Alcohol Dependence, 110(1–2), 55–60.	Stockwell, T., Murphy, D., & Hodgson, R. (1983). The Severity of Alcohol Dependence Questionnaire: Its use, reliability and validity. British Journal of Addiction, 78(2), 145–155.
Outros nomes	DUDIT	BAM	CUDIT-R, CUDIT	SADQ
Relacionados	4	4	4	4
Resumo	The DUDIT is a brief, gender-sensitive screening instrument designed to identify individuals with harmful or hazardous drug use patterns across a wide range of substances. Developed by Berman and colleagues in 2005, it serves as a primary care and public health screening tool to detect drug-related problems before they escalate to dependence or disorder. The DUDIT is freely available and has been validated in multiple languages and settings.	The BAM is a 17-item self-report instrument designed to provide rapid, multimodal assessment of substance use, craving, risk factors, protective factors, and psychosocial functioning in individuals receiving addiction treatment. Developed by Cacciola and colleagues in 2013, it serves as an efficient outcome monitoring tool for tracking treatment progress, identifying relapse warning signs, and guiding therapeutic adjustments. The BAM is useful in treatment settings where frequent assessment of multiple domains is needed to optimize care.	The CUDIT-R is a brief, 8-item self-report screening instrument developed to identify cannabis use disorder and hazardous cannabis use patterns. Introduced by Adamson and colleagues in 2010 as a revision of the original CUDIT, the CUDIT-R improves brevity and screening efficiency while maintaining strong psychometric properties. It is designed for use in primary care, addiction treatment, and public health settings to detect problematic cannabis use and inform treatment allocation decisions.	The SADQ is a 20-item self-report instrument that measures the severity of alcohol dependence on a continuum from mild to severe. Developed by Stockwell and colleagues in 1979, it quantifies physical withdrawal symptoms, psychological dependence, and behavioral indicators of dependence to guide treatment intensity and medical management decisions. The SADQ remains a widely used assessment tool in addiction medicine and alcohol treatment settings.